The effect of a selective α2-adrenoceptor antagonist on pain behavior of the rat varies, depending on experimental parameters

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 2, 1998, Pages 477-485

  Kauppila, Timo ^a   Jyväsjärvi, Erkki ^a   Hämäläinen, Minna M ^a   Pertovaara, Antti ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Antinociception; Atipamezole; Idazoxan; Medetomidine; Pain; Rat; 2 Adrenoceptor

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATIPAMEZOLE; IDAZOXAN; MEDETOMIDINE; 4 AMINOBUTYRIC ACID A RECEPTOR; FORMALDEHYDE; IMIDAZOLE DERIVATIVE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; FACILITATION; FOREFOOT; HABITUATION; HINDLIMB; LATENT PERIOD; LICKING; LOCUS CERULEUS; MECHANICAL STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN; STIMULATION; ANIMAL; ANIMAL BEHAVIOR; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; ELECTROPHYSIOLOGY; MALE; NERVE CELL; PAIN ASSESSMENT; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REFLEX; SPINAL CORD; WISTAR RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; FORMALDEHYDE; IMIDAZOLES; MALE; NEURONS; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, GABA-A; RECEPTORS, OPIOID; REFLEX; SPINAL CORD;

EID: 0031987343     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00393-6     Document Type: Article

References (49)

1. Abbott F. V., Franklin K. B., Connell B. The stress of a novel environment reduces formalin pain. possible role of serotonin Eur. J. Pharmacol. 126:1986;141-144.
2. Baldwin H. A., Johnston A. L., File S. E. Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur. J. Pharmacol. 159:1989;211-215.
3. Berge O. G., Fasmer O. B., Hole K. Serotonin receptor antagonists induce hyperalgesia without preventing morphine antinociception. Pharmacol. Biochem. Behav. 19:1983;873-878.
4. Camarata P. J., Yaksh T. L. Characterization of the spinal adrenergic receptors mediating the spinal effects produced by the microinjection into the periaqueductal gray. Brain Res. 336:1985;133-142.
5. Carter R. B. Differentiating analgesic and nonanalgesic drug activities on rat hot plate. Effect of behavioral endpoint Pain. 47:1991;211-220.
6. Charney D. S., Heninger G. R., Redmond D. E. Jr. Yohimbine induced anxiety and increased noradrergic function in humans. Effects of diazepam and clonidine Life Sci. 33:1983;19-29.
7. Coderre T. J., Rollman G. B. Naloxone hyperalgesia and stress-induced analgesia in rats. Life Sci. 32:1983;2139-2146.
8. D'Amour F. E., Smith D. L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
9. Dennis S. G., Melzack R., Gutman S., Boucher F. Pain modulation by adrenergic agents and morphine as measured by three pain tests. Life Sci. 26:1980;1247-1259.
10. Doze V. A., Chen B. X., Maze M. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2-adrenoceptors. Anesthesiology. 71:1989;75-79.
11. 2adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice. Psychopharmacology (Berlin). 97:1989;189-193.
12. 2-adrenoceptor antagonists. Alcohol. 6:1989;189-192.
13. Espejo E. F., Mir D. Structure of the rats' behaviour in the hot plate test. Behav. Brain Res. 56:1993;171-176.
14. Haffner F. Experimentelle Prüfung schmerzstillender Mittel. Deutsch. Med. Wsch. 55:1929;731-733.
15. Hammond D. L. Interference of pain and its modulation from simple behaviors. Chapman C. R., Loeser J. D. Issues in pain management. 1989;69-91 Raven Press, New York.
16. Handley S. L., Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze exploration model of 'fear-motivated' behaviour. Naunyn Scmiedebergs Arch. Pharmacol. 327:1984;1-5.
17. Hylden J. L. K., Thomas D. A., Iadarola M. A., Nahin R. L., Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia. Possible involvement of noradrergic mechanisms Eur. J. Pharmacol. 194:1991;135-143.
18. Idänpään-Heikkilä J. J., Kalso E. A., Seppälä T. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal mechanical and inflammatory stimuli. J. Pharmacol. Exp. Ther. 271:1994;1306-1313.
19. Iglesias V., Alguacil L. F., Alamo C., Cuenca E. Effects of yohimbine on morphine analgesia and physical dependence in the rat. Eur. J. Pharmacol. 211:1992;35-38.
20. Jalanka H. The use of medetomidine, medetomidine-ketamine combinations and atipamezole at Helsinki Zoo - A review of 240 cases. Acta Vet. Scand. 30(Suppl. 85):1989;193-197.
21. 2-adrenergic agonist. Pharmacol. Toxicol. 68:1991;140-143.
22. Kanui T. I., Tjolsen A., Lund A., Mjellem-Joly N., Hole K. Antinociceptive effect of intrathecal administration of alpha-adrenoceptor antagonists and clonidine in the formalin test in the mouse. Neuropharmacology. 32:1993;367-371.
23. Karhuvaara S., Kallio A., Scheinin M., Anttila M., Salonen J. S., Scheinin H. Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha-2-adrenoceptor antagonist - A randomized, double blind cross over study in healthy male volunteers. Br. J. Clin. Pharmacol. 30:1990;97-106.
24. 2-adrenoceptor agonist effects by atipamezole in human volunteers. Br. J. Clin. Pharmacol. 31:1991;160-165.
25. 2-adrenoceptor antagonist, in open-field, plus maze, two compartment exploratory, and forced swimming tests in the rat. Eur. J. Pharmacol. 205:1991;177-182.
26. 2-adrenoceptor antagonist, on the anesthesia induced by barbiturates and medetomidine. Anesth. Analg. 75:1992;416-420.
27. Kayser V., Guilbaud G., Besson J. M. Potent antinociceptive effects of clondine systemically administered in an experimental model of clinical pain, the arthritic rat. Brain Res. 593:1992;7-13.
28. 2-adrenergic agents on mustard oil-induced central hyperalgesia in rats. Eur. J. Pharmacol. 281:1995;43-48.
29. 2-receptors mediate the antinociceptive action of 8-OH-DPAT in the hot plate test in the mice. Brain Res. 539:1991;342-346.
30. Näsström J., Karlsson U., Berge O. G. Systemic and intracerebroventricular injection of NMDA receptor antagonists attenuates the antinociceptive activity of intrathecally administered NMDA receptor antagonists. Brain Res. 623:1993;47-55.
31. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, New York.
32. 2-adrenoceptor agonist, in various pain tests. Eur. J. Pharmacol. 179:1990;323-328.
33. Pertovaara A., Kauppila T., Jyväsjärvi E., Kalso E. Involvement of supraspinal and spinal segmental mechanisms in the medetomidine-induced antinociception. Neuroscience. 44:1991;705-714.
34. 2-adrenergic antinociception from sedation following microinjection of medetomidine into the locus coeruleus in rats. Pain. 57:1994;207-215.
35. Randall L. O., Selitto J. J. A method for measurement of analgetic activity on inflammed tissue. Arch. Int. Pharmacodyn. Ther. 111:1957;409-419.
36. Rochford J. The effects of clonidine and yohimbine on novelty-induced hypoalgesia. Psychobiology. 20:1992;163-168.
37. Rochford J., Dawes P. Clonidine and yohimbine modulate the effects of naloxone on novelty-induced hypoalgesia. Psychopharmacology (Berlin). 107:1992;575-580.
38. Rosland J. H., Hunskaar S., Hole K. Diazepam attenuates morphine antinociception test-dependently in mice. Pharmacol. Toxicol. 66:1990;382-386.
39. 2-adrenoceptor antagonist. Eur. J. Pharmacol. 157:1988;35-42.
40. Sirviö J., Mazurkiewicz M., Haapalinna A., Riekkinen P. Jr., Lahtinen H., Riekkinen P. J. Sr. The effects of selective alpha-2-adrenergic agents on the performance of rats in a 5-choice serial reaction time task. Brain Res. Bull. 35:1994;451-455.
41. Takano Y., Yaksh T. L. Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist. J. Pharmacol. Exp. Ther. 258:1991;438-446.
42. Tanila H., Kauppila T., Taira T. Inhibition of intestinal motility and reversal of postlaparotomy ileus by selective alpha2-adrenergic drugs in the rat. Gastroenterology. 104:1993;819-824.
43. Tasker R. A. R., Melzack R. Different alpha-receptor subtypes are involved in clonidine produced analgesia in different pain tests. Life Sci. 44:1989;9-17.
44. Tasker R. A., Connell B. J., Yole M. J. Systemic injections of alpha-1 adrenergic agonists produce antinociception in the formalin test. Pain. 49:1992;383-391.
45. Tjolsen A., Lund A., Hole K. The role of descending noradrenergic systems in regulation of nociception. the effects of intrathecally administered alpha-adrenoceptor antagonists and clonidine Pain. 43:1990;113-120.
46. 2-adrenoceptors by atipamezole. Arch. Int. Pharmacodyn. Ther. 297:1989;190-204.
47. Weinger M. B., Bednarczyk J. M. Atipamezole, an alpha-2-antagonist, augments opiate-induced muscle rigidity in the rat. Pharmacol. Biochem. Behav. 49:1994;523-529.
48. Wikberg J. E. S., Uhlén S., Chhajlani V. Medetomidine stereoisomers delineate two closely related subtypes of idazoxan (imidazoline) I-receptors in the quinea pig. Eur. J. Pharmacol. 193:1991;335-340.
49. Willis W. D., Coggeshall R. E. Sensory mechanisms of the spinal cord. 2:1991;Plenum Press, New York.